Items where Subject is "R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology"

Up a level

Export as ASCII CitationBibTeXDublin CoreEP3 XMLEndNoteHTML CitationJSONMETSMultiline CSVObject IDsOpenURL ContextObjectRDF+N-TriplesRDF+N3RDF+XMLReferReference Manager	Atom RSS 1.0 RSS 2.0

• Library of Congress Subject Areas (58)
  • R Medicine (58)
    • RC Internal medicine (58)
      • RC254 Neoplasms. Tumors. Oncology (58)

Group by: Creators | Item Type | Date | No Grouping

Number of items at this level: 58.

• Baumforth, K. R. N., Birgersdotter, A., Reynolds, G. M., Wei, W., Kapatai, G., Flavell, J., Kalk, E., Piper, K., Lee, S. P., Machado, L., Hadley, K., Sundblad, A., Sjoberg, J., Bjorkholm, M., Porwit, A., Yap, L.-F., Teo, S., Grundy, R., Young, L. S., Ernberg, I., Woodman, C. and Murray, P. (2008) Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's Lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. The American Journal of Pathology. 173(1), pp. 195-204. 0002-9440.
• Boulter, L. and Beaulieu, K. (2009) Can professionals ease the burden faced by carers of cancer sufferers? Paper presented to: College of Occupational Therapists 33rd Annual Conference and Exhibition, Brighton, 23-26 June 2009. (Unpublished)
• Campbell, J. (2013) Increasing early detection of lung cancer. Invited Presentation presented to: Government Conference, Royal College of Surgeons, London, 28 November 2013. (Unpublished)
• Campbell, J., Rogers, S., Pyer, M. and Reddy, R. (2012) The early lung cancer detection initiative in Corby, Northamptonshire, UK. International Journal of Tuberculosis and Lung Disease. 16 (12)(Supp 1), S414. 1027-3719.
• Campbell, J., Rogers, S., Pyer, M. and Reddy, R. (2012) The early lung cancer detection initiative in Corby, Northamptonshire, UK. Poster presented to: 43rd Union World Conference on Lung Health, of the International Union Against Tuberculosis and Lung Disease, Kuala Lumpur, Malaysia, 13-17 November 2012. (Unpublished)
• Coskeran, T., Denman, A. R., Phillips, P. S., Gillmore, G. K. and Tornberg, R. (2006) A new methodology for cost effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within Primary Care Trusts in Central England. Science of The Total Environment. 366(1), pp. 32-46. 0048-9697.
• Denman, A. R., Coskeran, T., Phillips, P. S., Crockett, R. G. M. and Tornberg, R. (2007) Lowering the domestic radon level to prevent more lung cancers - is it cost effective? Paper presented to: 5th Conference on Protection Against Radon at Home and at Work, Prague, Czech Republic, 9-15 September 2007. (Unpublished)
• Denman, A. R., Coskeran, T., Phillips, P. S., Crockett, R. G. M., Tornberg, R. and Groves-Kirkby, C. J. (2008) Lowering the UK domestic radon Action Level to prevent more lung cancers - is it cost-effective? Journal of Radiological Protection. 28(1), pp. 61-71. 0952-4746.
• Denman, A. R., Eatough, J. P., Gillmore, G. and Phillips, P. S. (2003) Assessment of health risks to skin and lung of elevated radon levels in abandoned mines. Health Physics. 85(6), pp. 733-740. 0017-9078.
• Denman, A. R., Groves-Kirkby, C. J., Coskeran, T., Phillips, P. S., Crockett, R. G. M. and Tornberg, R. (2008) Lowering the UK domestic radon action level to reduce radiation-induced lung cancer in the general population - when and where is it cost effective? In: Abstracts of the 12th International Congress of the International Radiation Protection Association. p. 463.
• Denman, A. R., Groves-Kirkby, C. J., Timson, K., Shield, G., Rogers, S. and Phillips, P. S. (2008) Smoking cessation programmes in radon affected areas: can they make a significant contribution to reducing radon-induced lung cancers? Poster presented to: Faculty of Public Health Annual Conference, Cardiff, 3-5 June 2008. (Unpublished)
• Denman, A. R., Groves-Kirkby, C. J., Timson, S., Shield, G., Rogers, S. and Phillips, P. S. (2007) Can smoking cessation programmes make a significant contribution to lung cancer reduction in radon affected areas? Poster presented to: 5th Conference on Protection Against Radon at Home and at Work, Prague, Czech Republic, 9-15 September 2007. (Unpublished)
• Denman, A. R., Phillips, P. S., Coskeran, T., Groves-Kirkby, C. J., Crockett, R. G. M. and Tornberg, R. (2009) Carefully targeted radon reduction strategies are more appropriate (rapid response to Gray et al.). British Medical Journal. 338 0959-8138.
• Denman, A. R., Phillips, P. S., Groves-Kirkby, C. J., Timson, K., Shield, G., Rogers, S. and Campbell, J. (2010) Reducing lung cancer incidence by health campaigns : a review of the uptake, health benefits and cost effectiveness of smoking cessation and radon remediation programmes in Northamptonshire, UK. In: Proceedings of Third European IRPA Congress 2010 June 14-16, Helsinki, Finland.
• Denman, A. R., Phillips, P. S. and Tornberg, R. (2002) The costs and benefits of radon remediation programmes in existing homes: case study of action level selection. Journal of Environmental Radioactivity. 62(1), pp. 17-27. 0265-931X.
• Denman, A. R., Phillips, P. S., Tornberg, R. and Groves-Kirkby, C. J. (2005) Analysis of the individual health benefits accruing from a domestic radon remediation programme. Journal of Environmental Radioactivity. 79(1), pp. 7-23. 0265-931X.
• Denman, A. R., Timson, K., Shield, G., Groves-Kirkby, C. J., Rogers, S., Campbell, J. and Phillips, P. S. (2009) Local health campaigns to reduce lung cancers induced by radon and smoking - who responds? Health Policy. 93(2), pp. 201-206. 0168-8510.
• Denman, A. R., Timson, K., Shield, G., Groves-Kirkby, C. J., Rogers, S., Campbell, J. and Phillips, P. S. (2009) Local health campaigns to reduce lung cancers induced by radon and smoking – who responds? Invited Presentation presented to: Detecting the Evidence, Northampton, 02 April 2009. (Unpublished)
• Durrant, L. G., Ottensmeier, C. H., Mulatero, C., Lorigan, P., Plummer , R., Cunnell, M., Metheringham, R., Brentville, V., Machado, L., Daniels , I., Hannaman, D. and Patel, P. M. (2015) A clinical trial of a DNA vaccine (SCIB1) that targets dendritic cells in vivo in fully resected melanoma patients; a vaccine to prevent disease recurrence? Poster presented to: 15th International Conference on Progress in Vaccination Against Cancer (PIVAC-15), Tübingen, Germany, 06-08 October 2015.
• Durrant, L. G., Ottensmeier, C., Lorigan, P., Mulatero, C., Plummer, R., Cunell, M., Metheringham, R. L., Brentville, V. A. and Machado, L. (2014) Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma. Cancer Research. 74(19 Sup) 0008-5472.
• Durrant, L. G., Xue, L., Machado, L., Metheringham, R. L. and Brentville, V. A. (2014) DNA vaccines. In: Rees, R. C. (ed.) Tumor Immunology and Immunotherapy. Oxford: Oxford University Press. pp. 251-264.
• Ekberg, M. E., Callender, M., Hamer, H. and Rogers, S. (2014) Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme. European Journal of Cancer Prevention. 23(5), pp. 391-397. 0959-8278.
• Groves-Kirkby, C. J., Timson, K., Shield, G., Denman, A. R., Rogers, S. and Phillips, P. S. (2011) Lung cancer reduction from smoking cessation and radon remediation: a preliminary cost analysis in Northamptonshire, UK. Environment International. 37(2), pp. 375-382. 0160-4120.
• Groves-Kirkby, C. J., Timson, K., Shield, G., Denman, A. R., Rogers, S., Campbell, J., Phillips, P. S. and Ekberg, M. E. (2014) Influences motivating smokers in a radon-affected area to quit smoking. Perspectives in Public Health. 134(1), pp. 44-56. 1757-9139.
• Gϋthlin, C., Hinrichs, I., Walach, H. and Rostock, M. (2007) Homeopathic treatment in cancer patients – a retrospective data analysis. Paper presented to: International Congress on Complementary Medicine Research, Munich, Germany, 11-13 May 2007. (Unpublished)
• Hamilton, E., Machado, L., Reynolds, G. M., Taniere, P., Lee, S. P., Steven, N. and Ismail, T. (2006) Biomarkers of the immune response in primary colorectal cancer. Poster presented to: Annual Meeting of the British Society of Gastroenterology, Surgical Section in Association with the Association of Coloproctology (ACPGBI) and IBD Section Joint Symposium, Birmingham, UK, 20-23 March 2006. (Unpublished)
• Hargreaves, C., Iriyama, C., Rose-Zerilli, M., Lee, C., Potter, K., Ganderton, R., Hussain, K., Machado, L., Hollox, E. J., Coupland, S., Stackpole, M., Oates, M., Pettitt, A. R., Cragg, M. and Strefford, J. (2014) Genomic dissection of the Fcγ receptor region in the context of monoclonal antibody therapy. Blood. 124(21), p. 2996. 0006-4971.
• Kennedy, C. A., Gray, A. M., Denman, A. R. and Phillips, P. S. (1999) A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom. British Journal of Cancer. 81(7), pp. 1243-1247. 0007-0920.
• Kennedy, C. A., Gray, A. M., Denman, A. R. and Phillips, P. S. (2002) The cost-effectiveness of residential radon remediation programmes: assumptions about benefits stream profiles over time. Journal of Environmental Radioactivity. 59(1), pp. 19-28. 0265-931.
• Lee, S. P., Green, A. M., Machado, L., Patel, P., Thomas, W., Goodyear, O., Briggs, D., McDonald, D., Marsden, J. and Steven, N. (2005) Infusing advanced cancer patients with tumour antigen-specific CD4+ and CD8+ T cell clones. Poster presented to: Annual Congress of the British Society for Immunology, Harrogate, UK, 06-09 December 2005. (Unpublished)
• Lee, S. P., Hewitt, A., Thomas, W., Machado, L., Goodyear, O., Marsden, J., Van der, B., Briggs, D. and Steven, N. (2003) Generating cancer/testis antigen- and Epstein-Barr virus-specific T cell clones for adoptive immunotherapy. Poster presented to: Keystone Symposia on Molecular and Cellular Biology: Basic Aspects of Tumour Immunology, Colorado, USA, 2003. (Unpublished)
• Lynch, S. and Walach, H. (2007) Subjective effects of deep field relaxation, a form of spiritual healing, on cancer patients – a qualitative study. Paper presented to: International Congress on Complementary Medicine Research, Munich, Germany, 11-13 May 2007. (Unpublished)
• Machado, L., Jarrett, R., Morgan, S., Murray, P., Hunter, B., Crocker, J., Thomas, W., Steven, N., Ismail, T., Chapman, A., Adams, D. and Lee, S. P. (2007) Molecular mechanisms for T cell recruitment to Hodgkin's lymphoma. Poster presented to: Keystone Symposia on Molecular and Cellular Biology: The Potent New Anti-Tumor Immunotherapies, Banff, Alberta, Canada, 28 March - 02 April 2007. (Unpublished)
• Machado, L., Jarrett, R., Morgan, S., Murray, P., Hunter, B., Hamilton, E., Crocker, J., Thomas, W., Steven, N., Ismail, T., Chapman, A., Adams, D. H. and Lee, S. P. (2009) Expression and function of T cell homing molecules in Hodkins's lymphoma. Cancer Immunology, Immunotherapy. 58(1), pp. 85-94. 0340-7004.
• Machado, L., Moseley, P., Moss, R., Nolan, C., Rampage, J., Chan, S. and Durrant, L. G. (2014) High-mobility group protein 1 (HMGB1) is an independent predictor of poor survival in ovarian cancer. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 02-05 November 2014. Also presented at: British Society for Immunology Annual Congress (BSI2014), Brighton, UK, 01-04 December 2014 (Unpublished)
• Machado, L., Moseley, P. M., Moss, R., Deen, S., Nolan, C., Spendlove, I., Ramage, J., Chan, S. and Durrant, L. G. (2016) Downregulation of the citrullinating enzyme Peptidyl-arginine deiminase type-2 in ovarian cancer indicates poor prognosis. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, Liverpool, UK, 06-09 November 2016.
• Machado, L., Schmaler, T. T., Balasothy, M., Morgan, S., Larsen, M., Hislop, A., Murray, P., Mack, M., Adams, D., Van Hasselt, A., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2007) CXCR6 and CCR5 mediate recruitment of CD4 and CD8 T lymphocytes to nasopharyngeal carcinoma. Poster presented to: Cancer Research UK Midlands Regional Meeting, Birmingham, UK, April 2007. (Unpublished)
• Owton, H. (2011) Granny’s memoirs. Qualitative Inquiry. 17(5), pp. 459-460. 1077-8004.
• Parsonage, G., Machado, L., Hui, J. W.-Y., McLarnon, A., Schmaler, T., Balasothy, M., To, K.-F., Vlantis, A. C., Hasselt, C. A. V., Lo, K.-W., Wong, W.-L., Hui, E. P., Cheung Chan, A. T. and Lee, S. P. (2012) CXCR6 and CCR5 localize T lymphocyte subsets in nasopharyngeal carcinoma. American Journal of Pathology. 180(3), pp. 1215-1222. 0002-9440.
• Parsonage, G., Machado, L., Hui, J. W.-Y., Schmaler, T. T., Balasothy, M., Van Hasselt, A., Vlantis, L., Hui, E. P., Chan, A. T. C., Lo, K.-W. and Lee, S. P. (2010) T cell homing to nasopharyngeal carcinoma. Poster presented to: 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, University of Birmingham, 04-07 September 2010. (Unpublished)
• Patel, P. M., Durrant, L. G., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I. and Hannaman, D. (2014) Phase I trial of ImmunoBody in melanoma patients. Poster presented to: 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, McCormick Place, Chicago, Illinois, 30 May - 03 June 2014. (Unpublished)
• Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Hannaman, D., Cunnell, M., Metheringham, R. L., Brentville, V. A., Daniels, I., Machado, L. and Durrant, L. G. (2015) Abstract 9035: An adjuvant clinical trial of SCIB1, a DNA vaccine that targets dendritic cells in vivo, in fully resected melanoma patients. Journal of Clinical Oncology. 33(15 Sup) 0732-183X.
• Patterson, L. H., McKeown, S. R., Robson, T., Gallagher, R., Raleigh, S. M. and Orr, S. (1999) Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. Anti-Cancer Drug Design. 14(6), pp. 473-486. 0266-9536.
• Phillips, P. S. and Denman, A. R. (1997) Radon: a human carcinogen. Science Progress. 80(4), pp. 317-336. 0036-8504.
• Raleigh, S. M., Verschoyle, R. D., Bowskill, C., Pastorino, U., Staniforth, J. N., Steele, F., Dinsdale, D., Carthew, P., Lim, C. K., Silvester, J. and Gescher, A. (2000) Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol. British Journal of Cancer. 83(7), pp. 935-940. 0007-0920.
• Raleigh, S. M., Wanogho, E., Burke, M. D., McKeown, S. R. and Patterson, L. H. (1998) Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone di-N-oxide prodrug. International Journal of Radiation Oncology, Biology, Physics. 42(4), pp. 763-767. 0360-3016.
• Raleigh, S. M., Wanogho, E., Burke, M. D. and Patterson, L. H. (1999) Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug. Xenobiotica. 29(11), pp. 1115-1122. 0049-8254.
• Russell, L., Capasso, M., Vater, I., Akasaka, T., Bernard, O., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., Guttery, D., Haferlach, C., Harder, L., Heidenreich, O., Irving, J., Kearney, L., Nguyen-Khac, F., Machado, L., Minto, L., Majid, A., Moorman, A., Morrison, H., Rand, V., Strefford, J., Schwab, C., Tonnies, H., Dyer, M., Siebert, R. and Harrison, C. (2009) Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 114(13), pp. 2688-2698. 0006-4971.
• Russell, L., Capasso, M., Vater, I., Moorman, A., Akasaka, T., Harder, L., Heidenreich, O., Machado, L., Gest, S., Strefford, J., Chandrasekaran, T., Tonnies, H., Majid, A., Bernard, O., Dyer, M., Siebert, R. and Harrison, C. (2008) IGH@ translocations involving the pseudoautosomal region 1 (PAR1) of both sex chromosomes deregulate the cytokine receptor-like factor 2 (CRLF2) gene in B cell precursor acute lymphoblastic leukemia (BCP-ALL). Paper presented to: 50th American Society of Hematology (ASH) Annual Meeting and Exposition, San Francisco, California, 06-09 December 2008. (Unpublished)
• Singlehurst, H., Corr, S., Wilson, J. M. and Allen, S. (2010) Using autobiography to explore occupational transitions of those living with or beyond cancer. Paper presented to: World Federation of Occupational Therapists (WFOT) 15th World Congress, Santiago, Chile, 04-07 May 2010. (Unpublished)
• Walach, H. (2009) Mindfulness based approaches to oncology. Workshop presented to: Integrative Onkologie und Forschung, St Gallen, Switzerland, 30-31 October 2009. (Unpublished)
• Walach, H. (2009) Classical homeopathic treatment of tumor patients - a comparative cohort study. Alternative Therapies in Health and Medicine. 15(3), 128-129 and 152. 1078-6791.
• Walach, H. (2007) Spirituelle Therapieansätze – wissenschaftliche Beweisfϋhrung: eine Problematik. Paper presented to: Complementary Medicine meets Oncology Conference, Freiburg, Germany, 29-30 November 2007. (Unpublished)
• Walach, H., Guethlin, H., Naumann, J. and Rostock, M. (2009) Classical homeopathic treatment of tumour patients: a comparative cohort study. Poster presented to: North American Research Conference on Complementary & Integrative Medicine, Minneapolis, Minnesota, USA, 12-15 May 2009. (Unpublished)
• Walach, H., Schwarzer, T., Boencke, A., Mϋller, S., Seiter, C. and Weis, J. (2007) Subjective effects of deep field relaxation, a form of spiritual healing, on cancer patients – a qualitative study. Paper presented to: International Congress on Complementary Medicine Research, Munich, Germany, 11-13 May 2007. (Unpublished)
• Zheng, Y., Machado, L., Johnson, B., James, C., Parsonage, G. and Lee, S. P. (2010) EBV-specific T cell receptor gene transfer to target nasopharyngeal carcinoma. Poster presented to: 14th Biennial Conference of the International Association for Research on Epstein-Barr Virus and Associated Diseases, University of Birmingham, 04-07 September 2010. (Unpublished)
• Zheng, Y., Machado, L., Johnson, B., James, C., Parsonage, G. and Lee, S. P. (2009) T cell receptor gene transfer to target the Epstein-Barr virus-associated malignancy nasopharyngeal carcinoma. Poster presented to: National Cancer Research Institute (NCRI) Cancer Conference, University of Birmingham, UK, 05-07 October 2009. (Unpublished)
• Zheng, Y., Parsonage, G., Zhuang, X., Machado, L., James, C., Salman, A., Searle, P., Hui, E. P., Chan, A. T. C. and Lee, S. P. (2015) Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma. Cancer Immunology Research. 3(10), pp. 1138-1147. 2326-6066.

This list was generated from NECTAR on Sun Jun 30 16:18:38 2024 BST.